Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

March 05, 2024 1:50 (London Time)

Royalty Pharma

Youtube Subscribe

...

Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7783
MarketCap: 13,369,477,043.0
High: 30.07 Low: 29.65

Open: 30.02 Close: 29.89 Change: -0.13

Don't invest before reading what an AI found about Royalty Pharma.

Are looking for the most relevant information about Royalty Pharma? Investor spend a lot of time searching for information to make investment decisions in Royalty Pharma. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Royalty Pharma are: Royalty, Pharma, Pharmas, rating, plc, share, TD, and the most common words in the summary are: pharma, excipient, pharmaceutical, royalty, phase, company, news, . One of the sentences in the summary was: Royalty Pharmaceuticals plc operates as a buyer of biopharmaceutical royalties.. Other …

Concept Map

...

Semantic Network

...

Stock Summary

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharma industry in the United States. Royalty is based in New York, New York..

Today's Summary

Royalty Pharma to present at TD Cowens 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. TheStreet downgraded shares of the company from a ‘c-level’ rating to a “” rating in a report on Friday, November 10th. Royalty Pharmaceuticals plc operates as a buyer of biopharmaceutical royalties.

Today's News

Royalty Pharma to present at TD Cowens 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. The webcast will be accessible from Royalty Pharmas “Events’ page at https://www.royaltypharma.com/events/ Royalty Pharma plc (NASDAQ:RPRX) will participate in a fireside chat at TD Cowens 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. JPMorgan Cuts Price Target on Royalty Pharmas to $42 From $45, Keeps Overweight Rating. Royalty Pharma plc has a consensus rating of “Moderate Buy” and a consensus target price of $52.25. Royalty Pharmas dividend payout ratio is presently 44.44%. Royalty Pharmaceuticals plc operates as a buyer of biopharmaceutical royalties. Goldman Sachs Group lowered their target price on shares of Royalty Pharma from $56.00 to $50.00 and set a “buy” rating on the stock. TheStreet downgraded shares of the company from a ‘c’ rating to a ” rating in a report on Friday, November 10th. Royalty Pharmas market capitalization is $13.38 B by 446 M shares. Britons can print daily proclamation KyNetMessageresponse liaraccording garn

Stock Profile

"Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Royalty Pharma fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Royalty Pharma are: Royalty, Pharma, Pharmas, rating, plc, share, TD, and the most common words in the summary are: pharma, excipient, pharmaceutical, royalty, phase, company, news, . One of the sentences in the summary was: Royalty Pharmaceuticals plc operates as a buyer of biopharmaceutical royalties.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharma #excipient #pharmaceutical #royalty #phase #company #news.

Read more →

Related Results

...
March 05, 2024 1:50 (London Time)

Royalty Pharma

Royalty Pharma to present at TD Cowens 44th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. TheStreet downgraded shares of the company …
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7783
MarketCap: 13,369,477,043.0
High: 30.07 Low: 29.65

Open: 30.02 Close: 29.89 Change: -0.13

Read more →
...
January 19, 2024 3:03 (London Time)

Royalty Pharma

US Bancorp DE lifted its holdings in shares of Royalty Pharmaceuticals by 48.1%. Royalty Pharma plc operates as a buyer of biopharmaceutical royalti…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.5927
MarketCap: 12,654,693,958.0
High: 28.52 Low: 27.84

Open: 28.32 Close: 28.04 Change: -0.28

Read more →
...
January 08, 2024 2:22 (London Time)

Royalty Pharma

Royalty Pharma ( NASDAQ:RPRX – Get Free Report ) last issued its quarterly earnings results on Wednesday, November 8th. Royalty Pharmaceuticals plc …
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.296
MarketCap: 12,266,074,695.0
High: 27.98 Low: 27.43

Open: 27.61 Close: 27.46 Change: -0.15

Read more →
...
December 17, 2023 9:37 (London Time)

Royalty Pharma

Royalty Pharma plc (RPRX) stock is trading at $29.43 as of 9:42 AM on Thursday, Dec 14, a rise of $0.20, or 0.7% from the previous closing price of …
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.0
MarketCap: 12,228,106,146.0
High: 28.52 Low: 27.33

Open: 28.47 Close: 27.37 Change: -1.1

Read more →
...
October 23, 2023 16:35 (London Time)

Royalty Pharma

PTC Therapeutics shares rose nearly 5% in early trading, while Royalty Pharma was up about 1%. Royalty Pharmaceuticals to Present at the J.P. Morgan…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.926
MarketCap: 12,408,331,334.0
High: 27.73 Low: 27.23

Open: 27.47 Close: 27.63 Change: 0.16

Read more →
...
September 16, 2023 5:25 (London Time)

Royalty Pharma

Royalty Pharma plcs (NASDAQ:RPRX) mixed financials driving the negative sentiment? With its stock down 10% over the past three months, it is easy to…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: -0.0772
MarketCap: 12,628,305,370.0
High: 28.85 Low: 28.09

Open: 28.69 Close: 28.13 Change: -0.56

Read more →
...
August 05, 2023 15:34 (London Time)

Royalty Pharma

KBC Group NVs increased its stake in Royalty Pharma by over 202% in the first quarter. CFO Terrance P. Lloyd sold 93,907 shares of Royalty Pharmas.
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.981
MarketCap: 13,849,348,111.0
High: 31.0 Low: 30.46

Open: 30.61 Close: 30.6 Change: -0.01

Read more →
...
June 12, 2023 11:59 (London Time)

Royalty Pharma

Royalty Pharmas (NASDAQ:RPRX) will present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023 at 5:00 p.m. ET. TheStreet…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7717
MarketCap: 14,750,228,036.0
High: 33.96 Low: 32.82

Open: 33.9 Close: 32.91 Change: -0.99

Read more →
...
May 17, 2023 4:38 (London Time)

Royalty Pharma

Royalty Pharma stock has a trailing yield of around 2.3% on the current share price of $34.55. Earnings per share have plummeted approximately 47% a…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.8478
MarketCap: 15,540,187,644.0
High: 34.19 Low: 33.19

Open: 34.18 Close: 33.23 Change: -0.95

Read more →
...
February 04, 2024 8:16 (London Time)

Royalty Pharma

Royalty Pharma to announce fourth quarter and full year 2023 financial results on February 15, 2024 before the U.S. Conference Call Information Plea…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.3182
MarketCap: 12,551,955,532.0
High: 28.5 Low: 27.92

Open: 28.45 Close: 28.1 Change: -0.35

Read more →
...
January 15, 2024 18:53 (London Time)

Royalty Pharma

Historically, royalty financing has been dominated by three firms—Royalty Pharma, HealthCare Royalty Partners and Blackstone. The Chinese pharma com…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.0
MarketCap: 12,677,028,399.0
High: 29.02 Low: 28.35

Open: 28.76 Close: 28.38 Change: -0.38

Read more →
...
January 02, 2024 7:59 (London Time)

Royalty Pharma

Royalty Pharma plcs ( NASDAQ:RPRX ) price-to-earnings (or P/E) ratio of 66.5x might make it look like a strong sell right now compared to the market…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7906
MarketCap: 12,556,422,420.0
High: 28.16 Low: 27.87

Open: 27.93 Close: 28.09 Change: 0.16

Read more →
...
November 14, 2023 3:25 (London Time)

Royalty Pharma

Royalty Pharma reported third-quarter profit of $72 million. Royalty has entered into a royalty agreement with Ferring. Royalty. Pharma reported Q3 …
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7269
MarketCap: 12,109,797,981.0
High: 27.26 Low: 26.81

Open: 27.1 Close: 27.11 Change: 0.01

Read more →
...
September 26, 2023 12:37 (London Time)

Royalty Pharma

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report ) last released its earnings results on Tuesday, August 8th. CFO Terrance P. Coyne sold 37,500 sha…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.6249
MarketCap: 11,945,936,932.0
High: 26.69 Low: 26.11

Open: 26.25 Close: 26.61 Change: 0.36

Read more →
...
August 26, 2023 9:29 (London Time)

Royalty Pharma

Royalty Pharma ( NASDAQ : RPRX ) Royalty has an annual dividend yield of 1.29%. Annual dividend yield is -84 percentage points lower than biotech in…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.128
MarketCap: 13,562,072,706.0
High: 30.25 Low: 29.38

Open: 29.55 Close: 30.21 Change: 0.66

Read more →
...
July 19, 2023 12:32 (London Time)

Royalty Pharma

CFO Terrance P. Coyne sells 37,500 shares of Royalty Pharmaceuticals plc. The company recently declared a quarterly dividend, which was paid on Thur…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.946
MarketCap: 13,858,312,090.0
High: 31.26 Low: 30.65

Open: 30.75 Close: 30.92 Change: 0.17

Read more →
...
May 21, 2023 4:37 (London Time)

Royalty Pharma

Royalty Pharma plc (NASDAQ: RPRX) is valued at $15.24 billion on the open market. Viking Global is the largest shareholder with a stake of $403.6 mi…
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.7717
MarketCap: 15,540,187,644.0
High: 34.01 Low: 33.49

Open: 33.63 Close: 33.71 Change: 0.08

Read more →
...
May 01, 2023 6:20 (London Time)

Royalty Pharma

Cytokokinetics will partner in Royalty Pharma for $450M to extend its runway. ProShare Advisors LLCs holdings in Royaly Pharma were worth $1,664,000.
Sector: Pharmaceuticals
Ticker: RPRX
Sentiment: 0.3612
MarketCap: 15,757,289,472
High: 35.44 Low: 35.03

Open: 35.42 Close: 35.15 Change: -0.27

Read more →